Medinol

Tel Aviv, Israel Founded: 1992 • Age: 34 yrs
Thin cobalt-chrome stents are developed for coronary cardiovascular treatment.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 6 Services tracked
Competitors 10 Brand Intelligence

About Medinol

Medinol is a company based in Tel Aviv (Israel) founded in 1992 by Judith Richter and Kobi Richter. Medinol offers products and services including EluNIR, EluNIR-PERL, IoNIR, ChampioNIR, and Xemed Valve. Medinol operates in a competitive market with competitors including Silk Road Medical, Lifetech Scientific Corporation, Supira Medical, HDL Therapeutics and Transvascular, among others.

  • Headquarter Tel Aviv, Israel
  • Founders Judith Richter, Kobi Richter
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Medinol Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    N/A

    (Oct 14, 2001)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Medinol

Medinol offers a comprehensive portfolio of products and services, including EluNIR, EluNIR-PERL, IoNIR, ChampioNIR, and Xemed Valve.

Product name locked
Category locked
Primary

Ridaforolimus eluting stent system for enhanced coronary deliverability and treatment.

Product name locked
Category locked
Locked

Advanced stent with improved visibility for accurate implantation in challenging anatomy.

Product name locked
Category locked
Locked

Investigational drug-eluting scaffold for coronary artery disease management.

Product name locked
Category locked
Locked

Drug-eluting stent for peripheral artery disease with therapeutic drug delivery.

Product name locked
Category locked
Locked

Modular device for aortic valve replacement in structural heart procedures.

Product name locked
Category locked
Locked

Passive sensors for monitoring physiological data in cardiovascular implants.

People of Medinol

Headcount 200-500
Employee Profiles 47
Employee Profiles
People
Maor Elbaz
System Administrator
People
Marina Tikhonov-Demishtein
EVP, Global Commercialization
People
Yaniv Hetzroni
Head Of Labs And Technical Services
People
Eran Kaplan
SVP, Technologies

Unlock access to complete

Funding Insights of Medinol

Premium access

Detailed funding history for Medinol

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Medinol

Medinol has secured backing from 1 investor. Prominent investors backing the company include The Richters.

All
Investor Description Founded Year Domain Location
Alternative wedding photography and videography services are provided.
Locked Locked Locked
Premium access

Investor details for Medinol

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Medinol

Investments
Premium access

Investment portfolio details for Medinol

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Medinol

Premium access

Detailed financials for Medinol

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Medinol Comparisons

Medinol Primary company
Description
Thin cobalt-chrome stents are developed for coronary cardiov...
Location
Tel Aviv, Israel
Founded Year
1992
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Medinol

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Medinol

Medinol operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Silk Road Medical, Lifetech Scientific Corporation, Supira Medical, HDL Therapeutics and Transvascular, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of neuroprotection devices for carotid artery disease
Locked Locked Locked
Interventional devices for cardiovascular and vascular diseases are developed.
Locked Locked Locked
Developer of ventricular assist devices for coronary intervention and cardiogenic shock
Locked Locked Locked
Therapy to reverse coronary atherosclerosis is developed using patient plasma.
Locked Locked Locked
A TransAccess Catheter System that is used to deliver cells to damaged portions of the heart
Locked Locked Locked
Catheter ablation treatments for atrial fibrillation are developed.
Premium access

Detailed competitors of Medinol

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Medinol

Premium access

Complete news archive for Medinol

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Medinol

Medinol was founded in 1992.

Medinol is headquartered in Tel Aviv, Israel.

Judith Richter is the current CEO of Medinol. They have also founded this company.

Medinol develops metal stents, NIRxcell, made from thin cobalt-chrome alloy for the treatment of cardiovascular disease. It features their catheter technology, Flexx, having a spring-tip that eliminates tip flare-out and buckling. They are also developing an elastomer-based drug-eluting stent technology, eDES, which is currently in clinical studies. Medinol was founded by Dr. Judith Richter and Dr. Jacob (Kobi) Richter and they are currently holding the CEO and CTO positions respectively.

Medinol offers EluNIR, EluNIR-PERL, IoNIR, ChampioNIR, and 2 more products and services.

Medinol has 1 investor. Key investors include The Richters.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available